As the upstream of SLC31A1, AMPK and its agonist metformin can significantly improve SLC31A1 level by influencing Nedd4l interaction, which can be used in conjunction with metformin and copper chelating agent for breast cancer treatment [13]. Here, SLC31A1 is linked to breast carcinoma.